High-intensity statins are recommended for patients with peripheral artery disease (PAD).
Critical limb ischemia (CLI) is the most advanced presentation of PAD. The benefit of statins …

Objective The efficacy and cost effectiveness of atherectomy for femoropopliteal (FP) arterial
diseases have not been determined yet. A systematic review and meta-analysis were …

Background Endovascular treatment of calcified peripheral artery lesions may be associated
with suboptimal vessel expansion, increased complication risk, and reduced long-term …

Purpose: Optimal balloon angioplasty for infrapopliteal lesions is often limited by severe
calcification, which has been associated with decreased procedural success and lower long …

More than 200 million people worldwide have peripheral artery disease (PAD) or its most
severe manifestation, critical limb ischemia (CLI). While endovascular treatment has become …

Purpose: To examine whether laser atherectomy combined with drug-coated balloons
(laser+ DCB) can improve the outcomes of femoropopliteal (FP) in-stent restenosis (ISR) …

Introduction: The combination of intravascular lithotripsy (IVL) and drug-coated balloon
(DCB) angioplasty for calcified peripheral lesions is associated with promising short-term …

This study evaluated the outcomes of a bare metal stent (BMS), DCB alone, atherectomy
plus a drug-coated balloon (AT+ DCB) and AT alone for the treatment of femoropopliteal …

Background The long-term outcome of Jetstream atherectomy (JA) with or without adjunctive
drug coated balloons (DCB) in a real-world setting remains unknown. We report 16-month …

Purpose: To investigate the outcomes of orbital atherectomy (OA) for the treatment of
patients with peripheral artery disease (PAD) manifesting as claudication or chronic limb …